Search | Dengue Academy

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023

Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia

Takeda

2 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Dengue: Not Just 1 Virus, Not Just 1 Infection

Medscape

15 minutes
Antibody Levels over Time

Takeda

2 minutes
Immune response to dengue virus

Takeda

4 minutes
Dengue virus and pathobiology

Takeda

1 minutes
NS1 and its potential association with severe dengue

Takeda

3 minutes
Dengue - unanswered scientific questions

Takeda

11 minutes
Dengue serotypes

Takeda

4 minutes
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes

Takeda

2 minutes
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection

Takeda

2 minutes
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis

Takeda

2 minutes
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia

ADVA

25 minutes
Dengue Virus Life Cycle

HHMI BioInteractive

4 minutes
The Shifting Epidemiology of Dengue: From Climate Change to Urbanization

Medscape

5 minutes
Dengue disease awareness

ISID

39 minutes
Controlling Dengue: Immunization Is a Pillar of Prevention

Medscape

33 minutes
Dengue Prevention: Vaccination as Part of A Comprehensive Strategy for Disease Control

Takeda
Dengue Vaccines

Takeda
Dengue Vectors

Takeda

5 minutes
Vector control

Takeda

4 minutes
Dengue Phases & Guidelines

Takeda

4 minutes
Randomised trials of Wolbachia for dengue control – a step towards elimination?

ADVA

50 minutes
Impact of the COVID-19 Pandemic on the Global Dengue Situation

ADVA

79 minutes
Emerging Issues in Pediatric Dengue

WSPID

50 minutes
Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review

Takeda

2 minutes
Professor Adi Utarini – Eliminating Dengue

35 minutes
Dengue vector control: what works best

WSPID

20 minutes
Mosquito Longevity

ADVA

22 minutes
Dengue Prevention: Translating Knowledge into Action

Takeda

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023